The 2019 medical conference brings important information on managing arthritis among Hispanic patient populations.
There was an increased risk of many different kinds of side effects, but most were mild.
The 2019 medical conference brings important information on osteoarthritis drug therapies, better understanding of diseases causes and symptom management, and more ways to help patients feel better.
The 2019 medical conference brings important information on axSpA drug therapies, better understanding of diseases causes and symptom management, and more ways to help patients feel better.
The 2019 medical conference brings important information on RA drug therapies, better understanding of diseases causes and symptom management, and more ways to help patients feel better.
The 2019 medical conference brings important information on new drug therapies, better understanding of diseases causes and symptom management, and more ways to help patients feel better.
"Giant cell arteritis requires ongoing management, but it does not necessarily require continuous treatment.”
Researchers are very interested in seeing which factors might be used to predict — and help prevent — rheumatoid arthritis in at-risk people.
Screening is important because silent hepatitis B and C infections can spring to life when you start biologics or new synthetic DMARDs.
Researchers hope that identifying the link between respiratory issues and RA will result in better ways to prevent or screen for rheumatoid arthritis in people with lung disease.
New data compares what happens when the dosage of DMARDs such as methotrexate is tapered or kept steady.
Knowing there could be a lag between objective measures of improvement and patient-reported outcomes could help prevent over-treatment.
Although biologics cross the placenta, research shows they lead to few infections in babies after they’re born.
New data from the Centers for Disease Control and Prevention (CDC) suggests that arthritis might be a leading cause of chronic pain in the U.S.
"This may have implications for management decisions beyond treating to disease activity targets alone."
And a few factors seemed to be responsible, including being obese and also having fibromyalgia.
‘Art enables me to face my body and my life with courage.’
In new ArthritisPower research, whether or not medical marijuana is legal seems to affect whether patients use it, and importantly, whether they talk to their doctor about it.
But the majority of MTX users felt that the medication protects them from getting worse, according to a new study.
In new ArthritisPower research, patients said they wanted to track symptoms such as fatigue and aspects of mental health, such as depression and anxiety.